Total revenue was $8.9 million in the fourth quarter of fiscal 2025 compared to $7.3 million in the fourth quarter of fiscal 2024. During the quarter, the Company experienced transitional impacts from ...

Research and development expenses for the fiscal year ended March 31, 2025 were $16.9 million compared with $24.4 million for the fiscal year ended March 31, 2024. The decrease of $7.5 million was ...